Genetic Screening of Embryos: Promise adn Peril
Table of Contents
Choosing a name, a school, or a savings plan for a child used to be part of pre-parenthood decisions.Today, genetics joins that list, as new assisted reproduction tools allow for genetic analysis before birth, offering the potential to reduce disease risks but also sparking debate about the extent of human intervention in embryo advancement.
New technologies are allowing prospective parents to peek under the hood of their future children, but the ethical implications are complex.
- A company called Nucleus Embryo offers genetic analysis of embryos created through in vitro fertilization (IVF).
- The technology analyzes DNA to assess risk for over 900 hereditary conditions, including traits like height and intelligence.
- Experts caution that polygenic risk scores are not definitive predictors and raise ethical concerns about “designer babies.”
- Regulation of these technologies varies globally, with many countries limiting analysis to serious diseases.
Nucleus Embryo, presented as genetic analysis software, enables individuals undergoing in vitro fertilization (IVF) to compare the genetic profiles of embryos before implantation.The tool, according to the company, analyzes embryo DNA to evaluate more than 900 hereditary conditions, ranging from common diseases like diabetes and certain cancers to more controversial traits related to physical appearance, cognitive ability, and mental health.
The company was founded by Kian Sadeghi, who has publicly stated that parents should have the right to choose desirable traits in their children-such as height or intelligence-not just prevent serious illnesses. These statements have placed Nucleus Genomics at the centre of controversy.
How Does the Technology Work?
The technical process builds upon established assisted reproduction practices:
- In vitro fertilization (IVF): Several embryos are generated from eggs and sperm in a laboratory.
- Embryo genetic analysis: A small DNA sample from each embryo is examined to obtain genetic information.
- Scores and predictions: The system assigns genetic scores that place each embryo on a spectrum of risk or probability for certain conditions or traits.
This type of analysis is known as polygenic embryo screening or PGT-P (preimplantation genetic testing for polygenic disorders). Its objective is not to provide a definitive diagnosis, but to estimate probabilities based on genetic information.
What can Genetics Really predict?
What factors beyond genetics influence traits like intelligence and height? Human genetics doesn’t operate as a precise mathematical formula. Traits such as intelligence, height, or predisposition to common diseases are polygenic and multifactorial, meaning they depend on hundreds or thousands of genetic variants, alongside environmental factors like nutrition, education, social environment, and lifestyle.
Platforms like Nucleus Embryo utilize polygenic risk scores (PRS), which calculate a relative risk within a population. These scores indicate weather an embryo is slightly more or less likely to develop a certain condition compared to others, but they do not guarantee results. for example, an embryo with a favorable genetic score for lower cardiovascular disease risk could still develop the disease due to environmental factors.
Geneticists and doctors point out that PRS are useful for population studies, but their predictive capacity for individuals-and especially embryos-remains uncertain. Reviews published in Human Reproduction Update and other journals highlight the limitations of current PRS and the potential for misinterpretation.
Current evidence suggests that while relative risks can be estimated and useful genetic information provided, there are no guarantees when controlling for complex traits like intelligence or height. The debate continues as scientists, clinicians, and society balance the potential for disease prevention with the risks of turning human reproduction into a genetic optimization project.
Keep reading
